Back

MR-proANP and NT-proBNP as specific indicators of procedural success in patients with severe mitral regurgitation undergoing percutaneous mitral valve repair (MitraClip)

28 August 2018 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 6 - New predictors of outcome in valve disease Intervention ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Oliver Doerr

MVZ CCB Frankfurt und Main-Taunus GbR, Frankfurt am Main (Germany)

13 More presentations in this session

Presentation thumbnail
Doctor M. Desai (Cleveland, US)
Abstract Slides
Presentation thumbnail
Doctor W. Avila Samuel (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Doctor D. Kohalmi (Bonyhad, HU)
Abstract Slides
Presentation thumbnail
Doctor G. Papadopoulos (Duesseldorf, DE)
Abstract Slides
Presentation thumbnail
Doctor B. Mahon (Wellington, NZ)
Abstract

Access the full session

Session thumbnail
Poster Session 6 - New predictors of outcome in valve disease

The Event

Event poster

ESC Congress 2018

28 August 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
The role of NT ProBNP and Galectin 3 in the follow up of patients with primary mitral regurgitation
31 August 2025
thumbnail
Webinar
The year in cardiology 2018
12 December 2018
thumbnail
Congress Presentation
Clinical and haemodynamic effects of percutaneous edge-to-edge mitral valve repair in atrial versus ventricular functional mitral regurgitation
27 August 2021
thumbnail
Congress Presentation
Myocardial work as an independent predictor of postoperative NT-proBNP after transcatether aortic valve replacement
11 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources